INSM Company Profile and Key Details

Q: Who are the executives of INSM?

Eleanor BarisserAssociate Director of Investor RelationsMs. S. Nicole SchaefferChief People Strategy OfficerMr. Roger AdsettChief Operating OfficerDr. Martina Flammer M.B.A., M.D.Chief Medical OfficerMs. Sara M. Bonstein MBAChief Financial OfficerMr. John Goll IIISenior Vice President & Chief Accounting OfficerMandy FaheyExecutive Director of Corporation CommunicationsMr. John Drayton WiseSenior Vice President, Head of United States & Chief Commercial OfficerMr. Michael Alexander SmithSenior Vice President & Gen. CounselMr. William H. Lewis J.D., M.B.A.Pres, Chief Executive Officer & ChairmanMr. Michael Alexander Smith J.D.Senior Vice President, Gen. Counsel & Corporation Sec.Ms. S. Nicole Schaeffer M.B.A.Chief People Strategy OfficerMs. Sara M. Bonstein M.B.A., MBAChief Financial OfficerMr. Roger Adsett M.B.A.Chief Operating OfficerMr. John Drayton Wise M.B.A.Chief Commercial OfficerMr. Brian K. Kaspar Ph.D.Chief Scientific Officer

NASDAQ : INSM

Insmed

$125.08

-5.58-4.27%

At Close 4:00 PM

73.53

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Insmed Incorporated (INSM) stock declined over -4.27%, trading at $125.08 on NASDAQ, down from the previous close of $130.66. The stock opened at $129.15, fluctuating between $124.60 and $130.27 in the recent session.

Stock Snapshot

130.66

Prev. Close

27.11B

Market Cap

124.6

Day Low

-27.37

P/E Ratio

-4.57

EPS (TTM)

-3.79

Cash Flow per Share

129.15

Open

216.75M

Number of Shares

130.27

Day High

90.11%

Free Float in %

-2.29

Book Value

1.72M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 20, 2026	128.36	130.27	124.60	125.08	1.76M
Aug 19, 2026	129.85	131.10	127.42	130.66	1.48M
Aug 18, 2026	128.07	128.93	126.39	128.46	1.27M
Aug 17, 2026	124.71	128.46	124.70	128.32	1.9M
Aug 14, 2026	125.67	126.85	122.21	123.74	1.96M
Aug 13, 2026	132.50	133.16	126.13	126.33	2.47M
Aug 12, 2026	132.31	135.26	130.80	132.28	1.56M
Aug 11, 2026	134.55	135.30	131.67	132.57	2.73M
Aug 10, 2026	129.98	135.50	129.50	134.75	3.57M
Aug 07, 2026	134.99	135.49	126.44	131.10	4.9M
Aug 06, 2026	128.22	137.70	126.15	132.55	11.92M
Aug 05, 2026	99.16	100.95	98.64	99.02	4.9M
Aug 04, 2026	98.98	99.48	97.86	98.75	4.29M
Aug 03, 2026	98.20	100.00	96.42	98.45	3.55M
Jul 31, 2026	101.25	101.91	97.05	98.60	2.9M
Jul 30, 2026	101.63	102.10	99.03	101.49	3.36M
Jul 29, 2026	103.98	106.26	102.81	103.12	2.2M
Jul 28, 2026	104.73	105.76	103.18	104.13	1.95M
Jul 27, 2026	106.93	107.37	104.50	104.73	1.9M
Jul 24, 2026	106.49	108.27	105.77	106.92	1.9M

Contact Details

Bridgewater, NJ 08807

United States

https://www.insmed.com 908 977 9900

About Company

Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.

Stock Peers

ARGX

5.26+0.51%

argenx SE$1,038.12 REGN

-14.2-1.69%

Regeneron Pharmaceuticals, Inc.$826.64 VRTX

-11.8-2.14%

Vertex Pharmaceuticals Incorporated$540.26 UTHR

-8.14-1.54%

United Therapeutics Corporation$521.00 MDGL

-21.07-3.90%

Madrigal Pharmaceuticals, Inc.$519.09 ONC

-7.7-2.04%

BeOne Medicines AG$369.16 PRAX

-21.61-5.60%

Praxis Precision Medicines, Inc.$364.58 KRYS

-6.32-1.84%

Krystal Biotech, Inc.$337.02 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-3.32-1.14%

Ligand Pharmaceuticals Incorporated$287.39

Frequently Asked Questions

What is the current Insmed Incorporated (INSM) stock price?

Insmed Incorporated (NASDAQ: INSM) stock price is $125.08 in the last trading session. During the trading session, INSM stock reached the peak price of $130.27 while $124.60 was the lowest point it dropped to. The percentage change in INSM stock occurred in the recent session was -4.27% while the dollar amount for the price change in INSM stock was - $5.58.

INSM's industry and sector of operation?

The NASDAQ listed INSM is part of Biotechnology industry that operates in the broader Healthcare sector. Insmed Incorporated designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INSM?

Eleanor Barisser
Associate Director of Investor Relations
Ms. S. Nicole Schaeffer
Chief People Strategy Officer
Mr. Roger Adsett
Chief Operating Officer
Dr. Martina Flammer M.B.A., M.D.
Chief Medical Officer
Ms. Sara M. Bonstein MBA
Chief Financial Officer
Mr. John Goll III
Senior Vice President & Chief Accounting Officer
Mandy Fahey
Executive Director of Corporation Communications
Mr. John Drayton Wise
Senior Vice President, Head of United States & Chief Commercial Officer
Mr. Michael Alexander Smith
Senior Vice President & Gen. Counsel
Mr. William H. Lewis J.D., M.B.A.
Pres, Chief Executive Officer & Chairman
Mr. Michael Alexander Smith J.D.
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. S. Nicole Schaeffer M.B.A.
Chief People Strategy Officer
Ms. Sara M. Bonstein M.B.A., MBA
Chief Financial Officer
Mr. Roger Adsett M.B.A.
Chief Operating Officer
Mr. John Drayton Wise M.B.A.
Chief Commercial Officer
Mr. Brian K. Kaspar Ph.D.
Chief Scientific Officer

How INSM did perform over past 52-week?

INSM's closing price is 38.38% higher than its 52-week low of $90.39 where as its distance from 52-week high of $212.75 is -41.21%.

How many employees does INSM have?

Number of INSM employees currently stands at 1,664.

Link for INSM official website?

Official Website of INSM is: https://www.insmed.com

How do I contact INSM?

INSM could be contacted at phone 908 977 9900 and can also be accessed through its website. INSM operates from 700 US Highway 202/206, Bridgewater, NJ 08807, United States.

How many shares of INSM are traded daily?

INSM stock volume for the day was 1.72M shares. The average number of INSM shares traded daily for last 3 months was 3.58M.

What is the market cap of INSM currently?

The market value of INSM currently stands at $27.11B with its latest stock price at $125.08 and 216.75M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1664
Beta	0.79
Sales or Revenue	$305.21M
5Y Sales Change%	15.981%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	1664
Beta	0.79
Sales or Revenue	$305.21M
5Y Sales Change%	15.981%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

INSM Company Profile and Key Details

Insmed

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook

Company Overview